Efficacy of ranibizumab therapy combined with 2RT laser the wet form of age-related macular degeneration – a case report

Main Article Content

Dominika Pagacz

Abstract



 

The author presents a case of a 73-year-old woman with wet form of age-related macular degeneration treated with 2RT laserotherapy and intravitreal injections of ranibizumab. In this case active PRN (pro re nata) schedule with ranibizumab was applied. The result of ranibizumab therapy was right. There was no positive response to 2RT laserotherapy.


 

 



Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Pagacz D. Efficacy of ranibizumab therapy combined with 2RT laser the wet form of age-related macular degeneration – a case report. Ophthatherapy [Internet]. 2018Dec.31 [cited 2024Nov.22];5(4):224-7. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/543
Section
Articles

References

1. American Academy of Ophthalmology. Basic and Clinical Science Course. Część XII: Siatkówka i ciało szkliste. Wyd. I pol. Elsevier Urban and Partner, Wrocław 2005: 57-66.
2. Kański J, Milewski S. Choroby plamki. Wyd I pol. Górnicki Wydawnictwo Medyczne, Wrocław 2003: 26-30.
3. Rougier M, Dalyfer MN, Korobelnik JF. OCT and retina. Bordeaux University Hospital: 90-91.
4. Romanowska-Dixon B, Jakubowska B, Karska-Basta I. Swept Source OCT w diagnostyce różnicowej patologii tylnego odcinka oka i nowotworów wewnątrzgałkowych. Górnicki Wydawnictwo Medyczne, Wrocław 2018: 49.
5. Stankiewicz A, Figurska M, Kubicka-Trząska A. Diagnostyka różnicowa chorób tylnego bieguna gałki ocznej. Górnicki Wydawnictwo Medyczne, Wrocław 2016: 27.
6. Wylęgała E, Teper S, Wróblewska-Czajka E et al. Optyczna Koherentna Tomografia, Warszawa 2007: 72.
7. Virgili G, Michelessi M, Parodi MB et al. Laser treatment of drusen to prevent progression to advanced age related macular degeneration. Cochrane Database Syst Rev. 2015; (10): CD 006537.
8. Amadio M, Govoni S, Pascale A. Targeting VEGF in eye neovascularization. What´s new? A comprehensive review on current therapies and oligonucleotide-based intervention under development. Pharmacol Res. 2016; 103: 253-69.
9. Zerib J, Bourhis A, Cornut PL et al. Management of wet AMD in France 2015. J Fr Ophthalmol. 2017; 40(9): 723-30